This company has been marked as potentially delisted and may not be actively trading. (TMH) (TMH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock TMH vs. LH, DGX, DVA, CHE, CRVL, AMED, MD, AMN, and CCRNShould you be buying (TMH) stock or one of its competitors? The main competitors of (TMH) include Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), and Cross Country Healthcare (CCRN). These companies are all part of the "health care services" industry. (TMH) vs. Its Competitors Labcorp Quest Diagnostics DaVita Chemed CorVel Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Labcorp (NYSE:LH) and (TMH) (NYSE:TMH) are both health care services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations. Does the media prefer LH or TMH? In the previous week, Labcorp had 22 more articles in the media than (TMH). MarketBeat recorded 25 mentions for Labcorp and 3 mentions for (TMH). Labcorp's average media sentiment score of 1.25 beat (TMH)'s score of 0.00 indicating that Labcorp is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 21 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive (TMH) 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Which has preferable valuation and earnings, LH or TMH? Labcorp has higher revenue and earnings than (TMH). CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLabcorp$13.01B1.66$746M$9.0628.66(TMH)N/AN/AN/AN/AN/A Do analysts recommend LH or TMH? Labcorp currently has a consensus target price of $289.58, suggesting a potential upside of 11.52%. Given Labcorp's stronger consensus rating and higher probable upside, research analysts clearly believe Labcorp is more favorable than (TMH).Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Labcorp 1 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.62(TMH) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is LH or TMH more profitable? Labcorp has a net margin of 5.66% compared to (TMH)'s net margin of 0.00%. Labcorp's return on equity of 15.45% beat (TMH)'s return on equity.Company Net Margins Return on Equity Return on Assets Labcorp5.66% 15.45% 7.02% (TMH) N/A N/A N/A Do institutionals and insiders have more ownership in LH or TMH? 95.9% of Labcorp shares are owned by institutional investors. 0.8% of Labcorp shares are owned by company insiders. Comparatively, 1.3% of (TMH) shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryLabcorp beats (TMH) on 10 of the 11 factors compared between the two stocks. Get (TMH) News Delivered to You Automatically Sign up to receive the latest news and ratings for TMH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMH vs. The Competition Export to ExcelMetric(TMH) Industry SectorNYSE ExchangeMarket CapN/A$2.03B$2.03B$20.70BDividend YieldN/A13.69%13.67%3.67%P/E RatioN/A12.5112.2828.64Price / SalesN/A2,530,024.082,676,059.9557.35Price / CashN/A20.0557.4723.59Price / BookN/A3.103.104.32Net IncomeN/A-$457.87M-$461.08M$995.66M (TMH) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMH(TMH)N/A$49.59-1.6%N/AN/A$0.00N/A0.00N/ALHLabcorp4.8739 of 5 stars$261.34+0.5%$289.58+10.8%+18.4%$21.77B$13.01B28.8570,000Positive NewsDGXQuest Diagnostics4.7786 of 5 stars$170.81+2.0%$186.00+8.9%+19.3%$18.72B$9.87B20.4656,000Positive NewsDVADaVita4.843 of 5 stars$138.44-1.4%$167.40+20.9%-4.8%$10.60B$12.82B13.7276,000Earnings ReportAnalyst ForecastCHEChemed4.9853 of 5 stars$418.08+1.4%$579.75+38.7%-23.8%$6.03B$2.51B21.5015,695Dividend IncreaseInsider TradeCRVLCorVel1.4459 of 5 stars$86.71-2.1%N/A-11.2%$4.56B$895.59M47.215,075Earnings ReportAMEDAmedisys2.9311 of 5 stars$98.51-0.1%$100.50+2.0%+3.2%$3.24B$2.35B38.3319,000High Trading VolumeMDPediatrix Medical Group2.8669 of 5 stars$11.98-2.2%$16.67+39.1%+50.1%$1.05B$1.98B-11.864,305Earnings ReportAMNAMN Healthcare Services4.4748 of 5 stars$17.82-2.8%$32.08+80.0%-71.8%$702.15M$2.85B-4.122,968News CoverageEarnings ReportCCRNCross Country Healthcare3.6718 of 5 stars$13.04-3.0%$17.93+37.5%-20.4%$440.93M$1.26B-24.608,205Earnings Report Related Companies and Tools Related Companies LH Alternatives DGX Alternatives DVA Alternatives CHE Alternatives CRVL Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TMH) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (TMH) Please log in to your account or sign up in order to add this asset to your watchlist. Share (TMH) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.